From Matt Fleming <[email protected]>
Subject New Study: Biosimilars Can Cut Prices In Half!
Date October 2, 2024 6:00 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
PRI Health Care Alert

View this email in your browser ([link removed])
[link removed]
Biosimilars Often Reduce Prices by 50 Percent or More
PRI Study | October 1, 2024 | Wayne Winegarden

In the competitive biologic markets, biosimilars have reduced average prices by 56 percent.

The lower prices have reduced total expenditures by 51 percent in the competitive biologic markets even though total use is higher.

Developing biosimilars is a long and costly endeavor that can take up to 9 years and $300 million. Market conditions should encourage uptake and appropriate reimbursement for physicians and manufacturers.

Read here . . . ([link removed])
[link removed]
American Healthcare Broken? Says Who?
Newsmax | Sally C. Pipes | October 1, 2024

A new study from the Commonwealth Fund ranks the U.S. health system dead last among 10 developed nations.

But is healthcare in the United States really that bad?

A close look at the data suggests otherwise.

In fact, there's no better place in the world to get sick than the United States. Patients here enjoy much better access to cutting-edge, life-saving care than their peers abroad.
Read more... ([link removed])

------------------------------------------------------------
[link removed]

A British Lord's Warning: Steer Clear of Single-Payer Health Care
Forbes | Sally C. Pipes | September 30, 2024

This month, Lord Ara Darzi presented the United Kingdom's Secretary of State for Health and Social Care with a devastating report on the state of the National Health Service. An independent peer and surgeon, Lord Darzi concluded that "the National Health Service is in serious trouble."

Read more... ([link removed])

[link removed]

============================================================
** Twitter ([link removed])
** Facebook ([link removed])
** YouTube ([link removed])
** LinkedIn ([link removed])
** Instagram ([link removed])
** Website ([link removed])
Copyright © 2024 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
P.O. Box 60485 Pasadena, CA 91116

** ([link removed])

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
Screenshot of the email generated on import

Message Analysis

  • Sender: n/a
  • Political Party: n/a
  • Country: n/a
  • State/Locality: n/a
  • Office: n/a
  • Email Providers:
    • MailChimp